601567 三星醫療
按盤價 
31.210 +0.340 (+1.101%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 10,433,714 | 25.14% | 11,462,508 | 9,098,203 | 7,022,902 | 7,092,709 | |
| 減：營業總成本 | 8,580,663 | 23.94% | 9,763,005 | 8,045,107 | 6,520,178 | 6,279,015 | |
| 其中:營業成本 | 6,655,350 | 20.25% | 7,566,257 | 6,470,477 | 5,241,357 | 5,054,566 | |
| 財務費用 | 77,988 | -517.77% | (8,838) | (14,853) | 88,302 | 94,541 | |
| 資產減值損失 | (29,659) | -844.77% | (12,987) | (11,539) | (13,066) | (15,861) | |
| 公允價值變動收益 | (76,740) | -186.34% | 116,975 | (107,481) | 103,697 | 65,383 | |
| 投資收益 | 177,637 | -2.01% | 296,137 | 84,951 | 204,334 | 337,618 | |
| 其中：對聯營企業和合營企業的投資收益 | 150,787 | 9.73% | 230,272 | 189,892 | 134,226 | 118,764 | |
| 營業利潤 | 2,076,643 | 17.88% | 2,270,452 | 1,152,349 | 851,227 | 1,192,528 | |
| 利潤總額 | 2,117,707 | 20.34% | 2,262,067 | 1,152,047 | 846,813 | 1,188,533 | |
| 減：所得稅費用 | 294,928 | 13.09% | 341,263 | 187,042 | 139,204 | 227,654 | |
| 淨利潤 | 1,822,779 | 21.60% | 1,920,804 | 965,005 | 707,609 | 960,879 | |
| 減：非控股權益 | 7,083 | -26.32% | 17,102 | 16,889 | 17,567 | 4,759 | |
| 股東淨利潤 | 1,815,696 | 21.91% | 1,903,702 | 948,116 | 690,043 | 956,120 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.290 | 22.86% | 1.350 | 0.670 | 0.500 | 0.690 | |
| 每股派息 (元) * | -- | -- | 0.650 | 0.350 | 0.320 | 0.350 | |
| 每股淨資產 (元) * | 8.292 | 10.33% | 7.794 | 6.729 | 6.333 | 6.217 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 04/11/2024 09:39 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
